Careviso vs Silna Health
Updated October 16, 2026
Labs and specialty providers buried in prior authorization requests often compare Careviso and Silna Health. Careviso has years of experience with genetic testing labs and medical-benefit drugs through its seeQer platform, while Silna is a younger company that checks benefits, authorizations, and documents so therapy and specialty patients are cleared before care. Your specialty and the age of your workflows tend to point one way.
Our analysts compared Careviso and Silna Health on authorization coverage, benefits checks, documentation review, specialty focus, and staffing model, using the HIR review of each company and Silna's announcements. In the following sections, we compare them in one table, describe the provider each serves, and note what Silna launched this year.
Careviso vs Silna Health at a glance, October 2026
| What buyers weigh | Careviso | Silna Health |
|---|---|---|
| Pricing model | A platform for prior authorization, insurance checks, and cost estimates, with prices quoted for each customer. | Software and service packages for specialty provider groups, priced by quote. |
| What drives cost | Authorization volume, the size of your provider network, which seeQer modules you use (prior authorization, cost estimates, pharmacy benefit), and the support level. | Authorization volume, specialties covered, and how much human staff work comes with the software. |
| Who it is built for | Labs and specialty groups with high medical-benefit prior auth volume. | Specialty providers with recurring prior auth and benefits checks. |
| Transparency and estimates | PA plus eligibility and cost estimates in one seeQer workflow. Clear edge | Centered on clear-to-treat and auth follow-up rather than cost estimates. |
| Human ops with the software | Platform packaging for order workflows and PA submission routing. | AI plus human ops for auth submission and follow-up. Clear edge |
| Results | Scores 7.8 on authorization turnaround and access. Higher score | Scores 7.5 on clear-to-treat and auth throughput. |
| Getting live | Scores 7.3 on getting live with order workflows. | Scores 7.1 on getting the workflow live. |
| Time to full value | About 3 to 8 months | About 3 to 7 months |
| What you need first | A named prior authorization or access lead who can change how submissions work. | Enough specialty prior authorization volume to justify automation. |
| Deal-breaker | No one will own prior authorization problem cases. | You are a payer that needs a large utilization management suite for millions of members. |
| Pricing clarity score | 7.0 | 7.0 |
| HIR overall score | 7.6, Recommend. Higher score | 7.3, Recommend. |
| Best for | Labs and specialty groups drowning in medical-benefit prior auth volume. | Specialty providers drowning in recurring prior auth and benefits checks. |
| Not a fit for | Buyers who will not change how staff handle exceptions after automated submissions. | Payers building an enterprise UM suite for millions of lives. |
Which fits which buyer
Look at which services generate most of your authorization volume.
Choose Careviso if
- You are a lab or a practice with medical-benefit drug authorizations.
- You want a vendor with a long specialty track record.
- Patient cost estimates matter alongside approvals.
Choose Silna Health if
- You run therapy, behavioral, or post-acute services with recurring authorizations.
- Catching document gaps before submission is a priority.
- You want benefits monitoring for patients in ongoing care.
Verdict
Careviso scores higher and suits labs and drug-heavy specialties. Silna suits providers whose patients need repeat authorizations over months of care.
Ask each for first-pass approval rates in your specialty.
Where the two tools are headed in 2027 and beyond
Silna Health: Silna launched Predictive Document Intelligence, which checks clinical documents against payer rules before submission, on January 28, 2026.
Pilot each on one payer with high denial rates.
Methodology
Each row comes from the HIR reviews of Careviso and Silna Health, scored under the HIR method, and from each vendor's public pricing where it exists. Any published price for Careviso or Silna Health was checked on that vendor's own site on October 16, 2026.
A green check marks a clear edge for Careviso or Silna Health only where their review scores differ by at least 0.3 points or the two reviews show a plain difference. Rows with nothing published for either Careviso or Silna Health are left out, and time to full value for each adds up the rollout stages in its review.